New study: can a common painkiller tame back pain in spondyloarthritis?
NCT ID NCT07582146
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a drug called acemetacin can reduce pain and control disease activity in adults with active axial spondyloarthritis, a type of inflammatory arthritis that mainly affects the spine. About 150 people aged 18 to 65 will take a daily pill for 4 weeks. Researchers will measure pain levels, disease activity, and any side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS (AS) / RADIOGRAPHIC AXIAL SPA (R-AXSPA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital
Beijing, Beijing Municipality, 100853, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gut microbiome transplant ease axial spondyloarthritis?
- Can a biologic drug safely tame Back-Joint inflammation? a Real-World trial investigates
- Can video coaching help ease arthritis symptoms?
- Digital diary aims to decode painful flares in spine condition
- App-Based exercise program aims to ease arthritis symptoms in underserved patients
- Neck scan could predict heart attacks in arthritis patients